T-cell Based Immunotherapy for Head and Neck Cancer

Stopped The patients eligible for this trial do not exist anymore due to change in procedures.

Conditions

• Squamous Cell Carcinoma
• Head and Neck Cancer

Interventions

• BIOLOGICAL: cyclophosphamide, fludarabine, T-cell infusion, and Interleukin-2

Sponsor

Inge Marie Svane